Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
POSTED
05-26-23
How Gilead’s Supportive Culture Helps Working Parents: LJ’s Story
When LJ Mizzi joined Gilead in 2013, she already had a personal connection to the company. “A Gilead medicine saved the life of a loved one, so I was excited to begin a career here and to contribute in any way I could,” LJ says.
POSTED
05-11-23
Gilead Emphasizes Unique Ways To Hire Top Talent
When Jamari Brooks was looking for a new job last fall, he knew he wanted his future employer to have a few key qualities.
POSTED
05-04-23
Gilead Remains Steadfast in Support for Hepatitis C Elimination Efforts
The recent national conversation on hepatitis C (HCV) is an encouraging step towards viral hepatitis elimination in the U.S. With its long history of leadership in viral hepatitis, Gilead continues to support efforts that focus on HCV elimination.
POSTED
04-25-23
Gilead Sciences Releases Inaugural ESG Impact Report
Gilead Sciences recently released its inaugural Environmental, Social and Governance (ESG) Impact Report.
POSTED
04-20-23
Gilead Sciences: Breaking Down Barriers To Access in HIV and Beyond: A Perspective
When I came to Gilead in 2019, I did so in part because of the revolutionary way this company thinks about bringing therapies to those who could benefit.
POSTED
04-13-23
Gilead Sciences: 4 Questions: Global Experts Convene To Identify Key Measures to Long-Term Success in HIV
We sat down with Dan Murphy and Dr. Jeffrey Lazarus to discuss the work that needs to be done to meet the United Nations' (U.N.) goal of ending the HIV epidemic by 2030 and to fully meet the needs of people living with HIV around the world.
POSTED
04-06-23
Gilead Sciences: Overcoming COVID-19 in Early 2020: Keith’s Story
Early in 2020, Keith Prowell was making the most of his retirement in New York and staying active with swimming and tai chi. But as reports of a new, unknown virus started spreading, he began not feeling well.
POSTED
03-30-23
Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities
KM Uploading / MI approved.
POSTED
03-23-23
Groups Around the World Work to Eliminate Hepatitis C by Meeting People Where They Are
Every Friday for more than two years, a community church in North Wales, U.K., would transform into a one-stop shop of social services for people experiencing homelessness. Everything from housing to haircuts, mental health services and foot care by local podiatrists were offered
POSTED
03-16-23
Stacey Bledsoe’s Resolve To Make Clinical Trials Available to Everyone
Stacey came to Gilead last year because of its legacy and leadership in advancing health equity and access for underrepresented communities.
